Impact of Probiotic SYNBIO(®) Administered by Vaginal Suppositories in Promoting Vaginal Health of Apparently Healthy Women
- PMID: 27324341
- DOI: 10.1007/s00284-016-1085-x
Impact of Probiotic SYNBIO(®) Administered by Vaginal Suppositories in Promoting Vaginal Health of Apparently Healthy Women
Abstract
The purpose of this study was to investigate whether vaginal administration of probiotic Lactobacillus results in their colonization and persistence in the vagina and whether it promotes normalization and maintenance of pH and Nugent score. A single-arm, open-label controlled towards the baseline (pre-post) study including 35 apparently healthy women was conducted. Each woman was examined three times during the study. Women were instructed to receive daily for 7 days, the probiotic suppositories SYNBIO(®) gin (Lactobacillus rhamnosus IMC 501(®) and Lactobacillus paracasei IMC 502(®)). Vaginal swabs were collected during visit 1, 2, and 3 to determine the total lactobacilli count, the presence of the two administered bacteria, the measure of the pH, and the estimation of Nugent score. Evaluation of treatment tolerability was based on analysis of the type and occurrence of adverse events. The probiotic vaginal suppository was well tolerated and no side effects were reported. Intermediate Nugent score was registered in 40 % of women at visit 1 and these intermediate scores reverted to normal at day 7 (end of treatment) in 20 % of subjects. Administration of SYNBIO(®) gin contributed to a significant increase in the lactobacilli level at visit 2. Molecular typing revealed the presence of the two strains originating from SYNBIO(®) gin in 100 % of women at visit 2 and 34 % at visit 3. No significant changes were registered for pH between visits. The SYNBIO(®) gin product is safe for daily use in healthy women and it could be useful to restore and maintain a normal vaginal microbiota.
Similar articles
-
Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial.Drug Des Devel Ther. 2015 Sep 25;9:5345-54. doi: 10.2147/DDDT.S89214. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26451088 Free PMC article. Clinical Trial.
-
Studies on the effects of probiotic Lactobacillus mixture given orally on vaginal and rectal colonization and on parameters of vaginal health in women with intermediate vaginal flora.Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):210-5. doi: 10.1016/j.ejogrb.2012.05.001. Epub 2012 Jun 19. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22721635
-
Evaluation of antipathogenic activity and adherence properties of human Lactobacillus strains for vaginal formulations.J Appl Microbiol. 2014 May;116(5):1297-307. doi: 10.1111/jam.12459. Epub 2014 Feb 19. J Appl Microbiol. 2014. PMID: 24552173
-
Persistence of Lactobacilli in Postmenopausal Women - A Double-Blind, Randomized, Pilot Study.Gynecol Obstet Invest. 2017;82(2):144-150. doi: 10.1159/000446946. Epub 2016 Jul 5. Gynecol Obstet Invest. 2017. PMID: 27376550 Review.
-
Defence factors of vaginal lactobacilli.Crit Rev Microbiol. 2018 Feb;44(1):31-39. doi: 10.1080/1040841X.2017.1306688. Epub 2017 Apr 18. Crit Rev Microbiol. 2018. PMID: 28418713 Review.
Cited by
-
The Possible Role of Probiotic Supplementation in Inflammation: A Narrative Review.Microorganisms. 2023 Aug 26;11(9):2160. doi: 10.3390/microorganisms11092160. Microorganisms. 2023. PMID: 37764004 Free PMC article. Review.
-
Crosstalk between the Resident Microbiota and the Immune Cells Regulates Female Genital Tract Health.Life (Basel). 2023 Jul 9;13(7):1531. doi: 10.3390/life13071531. Life (Basel). 2023. PMID: 37511906 Free PMC article. Review.
-
Probiotic Strain Limosilactobacillus reuteri 29B is Proven Safe and Exhibits Potential Probiotic Traits in a Murine Vaginal Model.Probiotics Antimicrob Proteins. 2023 Jun 14. doi: 10.1007/s12602-023-10094-2. Online ahead of print. Probiotics Antimicrob Proteins. 2023. PMID: 37314695
-
Can probiotics enhance fertility outcome? Capacity of probiotics as a single intervention to improve the feminine genital tract microbiota in non-symptomatic reproductive-aged women.Front Endocrinol (Lausanne). 2023 Jan 19;13:1081830. doi: 10.3389/fendo.2022.1081830. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36743917 Free PMC article. Review.
-
Oral Intake of the Commercial Probiotic Blend Synbio® for the Management of Vaginal Dysbiosis.J Clin Med. 2022 Dec 20;12(1):27. doi: 10.3390/jcm12010027. J Clin Med. 2022. PMID: 36614828 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
